- Home
- DAWN vs PAVS Comparison
DAWN vs PAVS Comparison
Compare DAWN & PAVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DAWN | PAVS |
|---|---|---|
| Founded | 2018 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 624.8M | 45.1M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | DAWN | PAVS |
|---|---|---|
| Price | $9.28 | $2.24 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $26.56 | N/A |
| AVG Volume (30 Days) | 3.2M | ★ 5.4M |
| Earning Date | 11-04-2025 | 08-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $133,672,000.00 | $12,416,127.00 |
| Revenue This Year | $15.51 | N/A |
| Revenue Next Year | $49.99 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 31.11 | ★ 18037.91 |
| 52 Week Low | $5.64 | $1.65 |
| 52 Week High | $13.53 | $150.00 |
Technical Indicators
Market Signals| Indicator | DAWN | PAVS |
|---|---|---|
| Relative Strength Index (RSI) | 56.50 | 78.75 |
| Support Level | $8.13 | $0.02 |
| Resistance Level | $10.47 | $3.83 |
| Average True Range (ATR) | 0.62 | 0.17 |
| MACD | 0.08 | 0.23 |
| Stochastic Oscillator | 53.50 | 58.31 |
Price Performance
Historical ComparisonAbout DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd, through its subsidiaries, is involved in the AI-powered entertainment industry, to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It has entered into a software development agreement for the development of 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic. The group is also involved in an e-commerce business and provides TikTok-related e-commerce solutions for customers.